New monoclonal antibody therapeutics made straight from cancer patients’ blood
Some scientists use cancer patients as libraries for discovering novel immunotherapies.
oncology
Brain cancer meets its match with focused ultrasound treatment
Biomedical engineer Natasha Sheybani uses soundwaves to disrupt the blood-brain barrier and improve immunotherapy for glioblastoma patients.
A Balancing Act: Drug Discovery for Cancer
LIVE September 22nd, 2021 at 2:30 PM ET
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Bright Peak and Ajinomoto collaborate on immunocytokines
Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines
Liquid biopsy for the win in cancer
Twist Bioscience launches NGS methylation detection system for cancer analysis and epigenetic studies
Synthetic lethal drugs vs. cancer
Company obtains funding to advance precision oncology
Q&A: Engineering the immune system
Engineering and nanotechnology turn immune cells into a cancer drug delivery system
A novel option for solid tumors
InteRNA publishes preclinical data from investigational microRNA program
An agreement to advance BITR2101
Selexis and BITT enter agreement to advance BITT’s TNFR2 antagonist antibody therapy
Uncovering the origins of malignant rhabdoid tumors
Researchers discover how malignant rhabdoid tumors begin, and identify potential treatments
